This conclusion comes from studies where inhibition of NFκB/RelA signaling in bronchiolar small airway cells blocks RSV-induced inflammation and airway obstruction in vivo (Tian et al., 2018b). The gene discussed is NFKB1; the disease is Airway obstruction.